Step 2: Assess risk features Determine whether the patient is in dose escalation, has active GI symptoms, uses a high dose, has known gastroparesis, has long-standing diabetes with autonomic neuropathy, has severe GERD or hiatal hernia, or is undergoing general anesthesia/deep sedation
Therefore, further large-scale, prospective research is essential to refine these guidelines, ensure individualized patient safety, and improve overall perioperative outcomes
9 surprising reasons youre not losing weight You're Not Yet on a Therapeutic Dose One of the most common reasons a GLP-1 appears ineffective is that you're still in the dose-escalation phase
What other drugs will affect Lantus
Lemme Named 2025 Wellness Brand of the Year